The Mechanisms of PIM Kinase Inhibitor, SGI-1776 Free Base, in Treating Myeloma-Associated Bone Disease

被引:0
|
作者
Chen, Qingxiao
He, Jingsong
Gu, Huiyao
Huang, Xi
Chen, Jing
Fan, Zhang En
Guo, Xing
Yan, Haimeng
Huang, He
Cai, Zhen
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3079
引用
收藏
页数:2
相关论文
共 19 条
  • [1] he mechanisms of PIM kinase inhibitor, SGI-1776 free base, in treating myeloma associated bone disease
    Qingxiao, C.
    Gu, H.
    Qu, J.
    Chen, J.
    Zhang, E.
    He, J.
    Cai, Z.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 630 - 630
  • [2] Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
    Chen, Lisa S.
    Redkar, Sanjeev
    Taverna, Pietro
    Cortes, Jorge E.
    Gandhi, Varsha
    BLOOD, 2011, 118 (03) : 693 - 702
  • [3] SGI-1776, A NOVEL PIM KINASE INHIBITOR, FOR THE TREATMENT OF CANCER
    de Vos, S.
    Azab, A.
    Izumi, R.
    Navarro, T.
    Taverna, P.
    Redkar, S. G.
    Warner, S.
    Bearss, D.
    Choy, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 13 - 13
  • [4] In vivo activity of SGI-1776, an orally active Pim kinase inhibitor
    Bearss, D.
    Gourley, E.
    Liu, X. H.
    Bearss, J.
    Jones, C.
    Olsen, C.
    Vollmer, D.
    Warner, S.
    Vankayalapati, H.
    Severson, P.
    EJC SUPPLEMENTS, 2008, 6 (12): : 105 - 106
  • [5] Discovery of SGI-1776, a potent and selective Pim-1 kinase inhibitor
    Liu, Xiaohui
    Gourley, Eric
    Lamb, Jeremy
    Grand, Cory
    Lloyd, Marcy
    Warner, Steven
    Wolfe, Bradley
    Bearss, David
    Vankayalapati, Hariprasad
    CANCER RESEARCH, 2009, 69
  • [6] Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
    Chen, Lisa S.
    Redkar, Sanjeev
    Bearss, David
    Wierda, William G.
    Gandhi, Varsha
    BLOOD, 2009, 114 (19) : 4150 - 4157
  • [7] Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma
    Yang, Qingshan
    Chen, Lisa S.
    Neelapu, Sattva S.
    Miranda, Roberto N.
    Medeiros, L. Jeffrey
    Gandhi, Varsha
    BLOOD, 2012, 120 (17) : 3491 - 3500
  • [8] SGI-1776: A novel PIM kinase inhibitor with potent preclinical activity against Acute Myeloid Leukemia (AML)
    Swords, Ronan
    Kelly, Kevin
    Medina, Ernest
    Mahalingam, Devalingam
    Nawrocki, Steffan
    Bearss, David
    Ninomoto, Joi
    Berk, Gregory
    Giles, Francis
    Carew, Jennifer
    CANCER RESEARCH, 2009, 69
  • [9] The novel PIM kinase inhibitor SGI-1776 significantly enhances the preclinical activity of sunitinib in renal cell carcinoma
    Mahalingam, Devalingam
    Medina, Ernest
    Swords, Ronan T.
    Kelly, Kevin R.
    Bearss, David
    Choy, Gavin
    Taverna, Pietro
    Carew, Jennifer S.
    Giles, Francis J.
    Nawrocki, Steffan T.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [10] OVERCOMING DRUG RESISTANCE WITH SGI-1776: A NOVEL PIM KINASE INHIBITOR WITH POTENT PRECLINICAL ACTIVITY IN ACUTE MYELOID LEUKEMIA
    Swords, T.
    Kelly, K.
    Mahalingam, D.
    O'Dwyer, M.
    Nawrocki, S.
    Giles, F.
    Carew, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 306 - 306